Literature DB >> 27721258

Inhibitory roles of miR-320 in osteosarcoma via regulating E2F1.

Haojie Wu1, Weihua Li1, Minghui Zhang1, Shutao Zhu1, Dengfeng Zhang1, Xiao Wang1.   

Abstract

OBJECTIVES: Osteosarcoma (OsC) is the most common primary bone malignant tumor with lower incidence and high degree of malignancy, but the exact mechanism remains unknown. More evidence demonstrated microRNAs (miRNAs) could contribute to tumor progression. In this study, we investigated the expression and functions of miR-320 in OsC cells.
MATERIALS AND METHODS: miR-320 expression levels in several human OsC cell lines and human normal osteoblastic cell line were tested by quantitative real-time reverse transcription polymerase chain reaction (qRT-PCR). U2OS cells were transfected with miR-320 mimics or negative control oligos. MTT assay and cell flow cytometry assay by PI staining were performed to access the cell growth rate. Bioinformatic prediction and luciferase assays were used to identify the predicted target E2F1. qRT-PCR and Western blot were performed to access the molecular alteration of E2F1.
RESULTS: miR-320 was decreased in human OsC cell lines. Heterogeneous expression of miR-320 inhibited cell proliferation and induced cell cycle arrest. Besides, we proved that miR-320 could directly regulate the expression of E2F1 in U2OS cells.
CONCLUSION: These data suggested that miR-320 regulates the proliferation and cell cycle by targeting E2F1 in human OsC progression.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27721258     DOI: 10.4103/0973-1482.191635

Source DB:  PubMed          Journal:  J Cancer Res Ther        ISSN: 1998-4138            Impact factor:   1.805


  11 in total

Review 1.  miRNA signatures in childhood sarcomas and their clinical implications.

Authors:  G M Viera; K B Salomao; G R de Sousa; M Baroni; L E A Delsin; J A Pezuk; M S Brassesco
Journal:  Clin Transl Oncol       Date:  2019-04-04       Impact factor: 3.405

2.  Heat shock transcription factor 1 promotes the proliferation, migration and invasion of osteosarcoma cells.

Authors:  Zhenhua Zhou; Yan Li; Qi Jia; Zhiwei Wang; Xudong Wang; Jingjing Hu; Jianru Xiao
Journal:  Cell Prolif       Date:  2017-04-01       Impact factor: 6.831

3.  Upregulation of long non-coding RNA NNT-AS1 promotes osteosarcoma progression by inhibiting the tumor suppressive miR-320a.

Authors:  Changhui Li; Shouyun Zhang; Tongguo Qiu; Yuanji Wang; David M Ricketts; Chao Qi
Journal:  Cancer Biol Ther       Date:  2018-11-29       Impact factor: 4.742

4.  Reciprocal regulation of miR-1205 and E2F1 modulates progression of laryngeal squamous cell carcinoma.

Authors:  Pei Li; Xi-Jun Lin; Yang Yang; An-Kui Yang; Jin-Ming Di; Qi-Wei Jiang; Jia-Rong Huang; Meng-Ling Yuan; Zi-Hao Xing; Meng-Ning Wei; Yao Li; Xiao-Hui Yuan; Zhi Shi; Hui Liu; Jin Ye
Journal:  Cell Death Dis       Date:  2019-12-04       Impact factor: 8.469

5.  Analysis of a Preliminary microRNA Expression Signature in a Human Telangiectatic Osteogenic Sarcoma Cancer Cell Line.

Authors:  Gaia Palmini; Cecilia Romagnoli; Simone Donati; Roberto Zonefrati; Gianna Galli; Francesca Marini; Teresa Iantomasi; Alessandra Aldinucci; Gigliola Leoncini; Alessandro Franchi; Giovanni Beltrami; Domenico Andrea Campanacci; Rodolfo Capanna; Maria Luisa Brandi
Journal:  Int J Mol Sci       Date:  2021-01-25       Impact factor: 5.923

6.  CircHECTD1 Regulates Cell Proliferation and Migration by the miR-320-5p/SLC2A1 Axis in Glioblastoma Multiform.

Authors:  Wen Li; Shanshan Wang; Boquan Shan; Xiang Cheng; Hui He; Jianbing Qin; Yi Tang; Heyan Zhao; Meiling Tian; Xinhua Zhang; Guohua Jin
Journal:  Front Oncol       Date:  2021-05-17       Impact factor: 6.244

Review 7.  MicroRNA 320, an Anti-Oncogene Target miRNA for Cancer Therapy.

Authors:  Yuanyuan Liang; Shun Li; Liling Tang
Journal:  Biomedicines       Date:  2021-05-23

8.  MicroRNA-320 Enhances Radiosensitivity of Glioma Through Down-Regulation of Sirtuin Type 1 by Directly Targeting Forkhead Box Protein M1.

Authors:  Tengfei Li; Ji Ma; Xinwei Han; Yongxu Jia; Huifeng Yuan; Shaofeng Shui; Dong Guo
Journal:  Transl Oncol       Date:  2018-01-11       Impact factor: 4.243

9.  Network analysis of microRNAs, genes and their regulation in diffuse and follicular B-cell lymphomas.

Authors:  Oshrat Hershkovitz-Rokah; Polina Geva; Mali Salmon-Divon; Ofer Shpilberg; Stella Liberman-Aronov
Journal:  Oncotarget       Date:  2018-01-05

10.  miR‑320‑3p is involved in morphine pre‑conditioning to protect rat cardiomyocytes from ischemia/reperfusion injury through targeting Akt3.

Authors:  Lan Cao; Shijun Chai
Journal:  Mol Med Rep       Date:  2020-05-27       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.